Beijing Konruns Pharmaceutical Co.,Ltd.

SHSE:603590 Stok Raporu

Piyasa değeri: CN¥3.7b

Beijing Konruns PharmaceuticalLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Beijing Konruns PharmaceuticalLtd's earnings have been declining at an average annual rate of -18.2%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 1.3% per year. Beijing Konruns PharmaceuticalLtd's return on equity is 4.2%, and it has net margins of 13.6%.

Anahtar bilgiler

-18.2%

Kazanç büyüme oranı

-17.5%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı-1.3%
Özkaynak getirisi4.2%
Net Marj13.6%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Sep 03
Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Recent updates

Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Sep 29
Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Sep 03
Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Gelir ve Gider Dağılımı

Beijing Konruns PharmaceuticalLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:603590 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2484611558463
30 Jun 2487413757378
31 Mar 2495416661185
31 Dec 2392015058995
30 Sep 2399914656899
30 Jun 2394611256091
31 Mar 238768153291
31 Dec 2286710152887
30 Sep 2280111452891
30 Jun 2272613045384
31 Mar 22755130460103
31 Dec 21810148481102
30 Sep 2185517950598
30 Jun 21916180568110
31 Mar 2194921660396
31 Dec 2080918353393
30 Sep 2085520455089
30 Jun 2087022056294
31 Mar 20944249587104
31 Dec 191,066266678109
30 Sep 191,038311684131
30 Jun 191,029313669116
31 Mar 1998227366991
31 Dec 1897326465780
30 Sep 1889721558740
31 Dec 1759147932232
31 Dec 1634619210238
31 Dec 1543619518539

Kaliteli Kazançlar: 603590 has high quality earnings.

Büyüyen Kar Marjı: 603590's current net profit margins (13.6%) are lower than last year (14.7%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 603590's earnings have declined by 18.2% per year over the past 5 years.

Büyüme Hızlandırma: 603590's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 603590 had negative earnings growth (-21.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).


Özkaynak Getirisi

Yüksek ROE: 603590's Return on Equity (4.2%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin